• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


2.5400 USD 0.1000 3.79%

As of 20:04:04 ET on 07/31/2014.

Snapshot for BioTime Inc (BTX)

Open: 2.5500 Day's Range: 2.5100 - 2.6300 Volume: 130,004
Previous Close: 2.6400 52wk Range: 2.2100 - 4.1800 1-Yr Rtn: -34.70%

Stock Chart for BTX

No chart data available.
  • BTX:US 2.5400
  • 1D
  • 1M
  • 1Y
Interactive BTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.5905
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 183.26
Shares Outstanding (M) 72.15
30 Day Average Volume 212,280
Price/Book (mrq) 9.5307
Price/Sale (ttm) 29.0599
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BTX

BioTime, Inc. researches and develops synthetic solutions that can be used as blood plasma volume expanders, blood replacement solutions during hypothermic surgery, and organ preservation solutions. The Company also operates in regenerative medicine sector, where it develops stem cell related products and technology for diagnostic, therapeutic and research use.

Michael D WestChief Executive OfficerWilliam P TewChief Commercial Officer
Robert W PeabodySenior VP/CFO/COO
More Company Profile & Key Executives for BTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil